Fecal calprotectin in daily practice for patients with inflammatory bowel disease: where do we stand in Korea?

참고문헌 (10)

1. Konikoff MR, "Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease", Inflamm Bowel Dis, 12, pp.524~534 (2006)
2. Nielsen OH, "Established and emerging biological activity markers of inflammatory bowel disease", Am J Gastroenterol, 95, pp.359~367 (2000)
3. Bjerke K, "Distribution of macrophages and granulocytes expressing L1 protein(calprotectin)in human Peyer’s patches compared with normal ileal lamina propria and mesenteric lymph nodes", Gut, 34, pp.1357~1363 (1993)
4. Roseth AG, "Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study", Scand J Gastroenterol, 27, pp.793~798 (1992)
5. Menees SB, "A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS", Am J Gastroenterol, 110, pp.444~454 (2015)
6. Roseth AG, "Normalization of faecal calprotectin : a predictor of mucosal healing in patients with inflammatory bowel disease", Scand J Gastroenterol, 39, pp.1017~1020 (2004)
7. Wassell J, "Evaluation of the Quantum Blue rapid test for faecal calprotectin", Ann Clin Biochem, 49(Pt 1), pp.55~58 (2012)
8. 이양운, "The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity", The Korean Journal of Internal Medicine, 34(1), pp.72~80 (2019), 대한내과학회[DOI]
9. Panes J, "Advances in use of endoscopy, radiology, and biomarkers to monitor inflammatory bowel diseases", Gastroenterology, 152, pp.362~373 (2017)[DOI]
10. Calafat M, "High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis: what is the best timing for stool sampling?", Inflamm Bowel Dis, 21, pp.1072~1076 (2015)

관련 논문AI추천